{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:13:27Z","timestamp":1793888007402,"version":"4.8.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Otolaryngol Head Neck Surg"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s12070-023-04309-9","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T16:02:28Z","timestamp":1699632148000},"page":"2176-2181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Biologics: The Good, the Bad and the Future of Ear, Nose and Throat"],"prefix":"10.1007","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4431-9166","authenticated-orcid":false,"given":"Victoria","family":"Vincent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,10]]},"reference":[{"issue":"4","key":"4309_CR1","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.otc.2021.04.001","volume":"54","author":"NC Schmitt","year":"2021","unstructured":"Schmitt NC, Monfared A, Wise SK (2021) Biologics in otolaryngology: past, present, and future. Otolaryngol Clin North Am 54(4):675\u2013687","journal-title":"Otolaryngol Clin North Am"},{"issue":"5","key":"4309_CR2","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/coa.13779","volume":"46","author":"C Hopkins","year":"2021","unstructured":"Hopkins C, McKenzie J-L, Anari S, Carrie S, Ramakrishnan Y, Kara N et al (2021) British rhinological society consensus guidance on the use of biological therapies for chronic rhinosinusitis with nasal polyps. Clin Otolaryngol 46(5):1037\u20131043","journal-title":"Clin Otolaryngol"},{"key":"4309_CR3","unstructured":"British National Formulary. Cetuximab [Internet]. Available from: https:\/\/bnf.nice.org.uk\/drugs\/cetuximab\/#indications-and-dose"},{"key":"4309_CR4","doi-asserted-by":"crossref","unstructured":"Chan JCN, Chan ATC (2017) Biologics and biosimilars: what, why and how? ESMO Open. 2: \u00a9 European Society for Medical Oncology (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted","DOI":"10.1136\/esmoopen-2017-000180"},{"key":"4309_CR5","unstructured":"Spriggs B (2021) Biological Treatments for Rheumatoid Arthritis: Healthline; [Available from: https:\/\/www.healthline.com\/health\/rheumatoid-arthritis\/understanding-biologic-treatments-for-ra"},{"issue":"6","key":"4309_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11882-021-01013-y","volume":"21","author":"B Geng","year":"2021","unstructured":"Geng B, Dilley M, Anterasian C (2021) Biologic therapies for allergic rhinitis and nasal polyposis. Curr Allergy Asthma Rep 21(6):36","journal-title":"Curr Allergy Asthma Rep"},{"key":"4309_CR7","first-page":"163752","volume":"2012","author":"P Specenier","year":"2012","unstructured":"Specenier P, Vermorken JB (2012) Biologic therapy in head and neck cancer: a road with hurdles. ISRN Oncol 2012:163752","journal-title":"ISRN Oncol"},{"key":"4309_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.12703\/P6-44","volume":"6","author":"JP Machiels","year":"2014","unstructured":"Machiels JP, Lambrecht M, Hanin FX, Duprez T, Gregoire V, Schmitz S et al (2014) Advances in the management of squamous cell carcinoma of the head and neck. F100Prime Rep 6:44","journal-title":"F100Prime Rep"},{"issue":"5","key":"4309_CR9","doi-asserted-by":"publisher","first-page":"103576","DOI":"10.1016\/j.amjoto.2022.103576","volume":"43","author":"B Balouch","year":"2022","unstructured":"Balouch B, Meehan R, Suresh A, Zaheer HA, Jabir AR, Qatanani AM et al (2022) Use of biologics for treatment of autoimmune inner ear disease. Am J Otolaryngol 43(5):103576","journal-title":"Am J Otolaryngol"},{"key":"4309_CR10","unstructured":"British National Formulary. Dupilumab [Internet]. Available from: https:\/\/bnf.nice.org.uk\/drugs\/dupilumab\/#interactions"},{"key":"4309_CR11","unstructured":"British National Formulary Omalizumab [Internet]. No date. Available from: https:\/\/bnf.nice.org.uk\/drugs\/omalizumab\/#side-effects"},{"key":"4309_CR12","unstructured":"British National Formulary. Etanercept [Internet]. No date. Available from: https:\/\/bnf.nice.org.uk\/drugs\/etanercept\/"},{"key":"4309_CR13","unstructured":"British National Formulary. Rituximab [Internet]. No date. Available from: https:\/\/bnf.nice.org.uk\/drugs\/rituximab\/"},{"key":"4309_CR14","unstructured":"British National Formulary. Medicinal forms: Omalizumab [Internet]. No date. Available from: https:\/\/bnf.nice.org.uk\/drugs\/omalizumab\/medicinal-forms\/"},{"key":"4309_CR15","unstructured":"British National Formulary. Medicinal forms: Prednisolone [Internet]. No date. Available from: https:\/\/bnf.nice.org.uk\/drugs\/prednisolone\/medicinal-forms\/#tablet"},{"key":"4309_CR16","unstructured":"British National Formulary. Medicinal forms: Dupilumab [Internet]. No date. Available from: https:\/\/bnf.nice.org.uk\/drugs\/dupilumab\/medicinal-forms\/"},{"key":"4309_CR17","unstructured":"Stephenson J (2018) NICE rejects breakthrough eczema jab on grounds of cost. Nursing Times [Internet]. Available from: https:\/\/www.nursingtimes.net\/news\/policies-and-guidance\/nice-rejects-breakthrough-eczema-jab-on-grounds-of-cost-03-04-2018\/"},{"key":"4309_CR18","unstructured":"National institute for Health and Care Excellence (2018) Dupilumab for treating moderate to severe atopic dermatitis [Internet]. Available from: https:\/\/www.nice.org.uk\/guidance\/ta534"},{"key":"4309_CR19","unstructured":"Skyler T (2022) Dupixent and cost: Reducing long-term drug costs and more. Medical News Today [Internet]. Available from: https:\/\/www.medicalnewstoday.com\/articles\/drugs-dupixent-cost#price"},{"issue":"4","key":"4309_CR20","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.anai.2019.12.001","volume":"124","author":"TM Laidlaw","year":"2020","unstructured":"Laidlaw TM, Buchheit KM (2020) Biologics in chronic rhinosinusitis with nasal polyposis. Ann Allergy Asthma Immunol 124(4):326\u2013332","journal-title":"Ann Allergy Asthma Immunol"},{"key":"4309_CR21","unstructured":"National Institute for Health and Care Excellence (2020) Mepolizumab for previously treated severe chronic rhinosinusitis with nasal polyps: draft scope [Internet]. Available from: https:\/\/www.nice.org.uk\/guidance\/gid-ta10701\/documents\/draft-scope-post-referral"},{"issue":"4","key":"4309_CR22","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jaip.2016.04.012","volume":"4","author":"WW Stevens","year":"2016","unstructured":"Stevens WW, Schleimer RP, Kern RC (2016) Chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract 4(4):565\u2013572","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"4309_CR23","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1080\/03007995.2020.1815682","volume":"36","author":"S Chen","year":"2020","unstructured":"Chen S, Zhou A, Emmanuel B, Thomas K, Guiang H (2020) Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis. Curr Med Res Opin 36(11):1897\u20131911","journal-title":"Curr Med Res Opin"},{"key":"4309_CR24","doi-asserted-by":"publisher","first-page":"104905","DOI":"10.1016\/j.micpath.2021.104905","volume":"155","author":"M Didehdar","year":"2021","unstructured":"Didehdar M, Khoshbayan A, Vesal S, Darban-Sarokhalil D, Razavi S, Chegini Z et al (2021) An overview of possible pathogenesis mechanisms of alternaria alternata in chronic rhinosinusitis and nasal polyposis. Microb Pathog 155:104905","journal-title":"Microb Pathog"},{"issue":"1","key":"4309_CR25","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/s41467-017-01211-1","volume":"8","author":"H Chassin","year":"2017","unstructured":"Chassin H, Geering B, Schukur L, Ausl\u00e4nder D, Lang B, Fussenegger M (2017) Sensing and responding to allergic response cytokines through a genetically encoded circuit. Nat Commun 8(1):1101","journal-title":"Nat Commun"},{"key":"4309_CR26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/B978-012088451-3.50019-3","volume-title":"The immune response","author":"TW Mak","year":"2006","unstructured":"Mak TW, Saunders ME (2006) 17-Cytokines and cytokine receptors. In: Mak TW, Saunders ME (eds) The immune response. Academic Press, Burlington, pp 463\u2013516"},{"issue":"4","key":"4309_CR27","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.otc.2021.05.005","volume":"54","author":"A Vambutas","year":"2021","unstructured":"Vambutas A, Davia DV (2021) Biologics for immune-mediated sensorineural hearing loss. Otolaryngol Clin North Am 54(4):803\u2013813","journal-title":"Otolaryngol Clin North Am"},{"issue":"6","key":"4309_CR28","first-page":"1125","volume":"68","author":"JE Isaacson","year":"2003","unstructured":"Isaacson JE, Vora NM (2003) Differential diagnosis and treatment of hearing loss. Am Fam Physician 68(6):1125\u20131132","journal-title":"Am Fam Physician"},{"key":"4309_CR29","unstructured":"Hearing Link Services (2022) Deafness and hearing loss facts [Internet]. Available from: https:\/\/www.hearinglink.org\/your-hearing\/about-hearing\/facts-about-deafness-hearing-loss\/"},{"key":"4309_CR30","unstructured":"Hain T (2022) Sensorineural hearing loss: dizziness-and-balance.com [Internet]. Available from: https:\/\/dizziness-and-balance.com\/disorders\/hearing\/sensorineural.htm"},{"issue":"4","key":"4309_CR31","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1177\/01945998211028796","volume":"166","author":"S Gorthey","year":"2022","unstructured":"Gorthey S, Patel R, Vambutas A (2022) Immune-mediated sensorineural hearing loss in the pediatric population. Otolaryngol Head Neck Surg 166(4):768\u2013771","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"7","key":"4309_CR32","first-page":"Cd008080","volume":"7","author":"SK Plontke","year":"2022","unstructured":"Plontke SK, Meisner C, Agrawal S, Cay\u00e9-Thomasen P, Galbraith K, Mikulec AA et al (2022) Intratympanic corticosteroids for sudden sensorineural hearing loss. Cochrane Database Syst Rev 7(7):Cd008080","journal-title":"Cochrane Database Syst Rev"},{"issue":"17","key":"4309_CR33","doi-asserted-by":"publisher","first-page":"6070","DOI":"10.1002\/cam4.4134","volume":"10","author":"MA Taylor","year":"2021","unstructured":"Taylor MA, Switchenko J, Stokes W, Patel MR, McDonald M, Steuer C et al (2021) Incidence trends of squamous cell carcinoma of the head and neck (SCCHN) in the aging population\u2013\u2013A SEER-based analysis from 2000 to 2016. Cancer Med 10(17):6070\u20136077","journal-title":"Cancer Med"}],"container-title":["Indian Journal of Otolaryngology and Head & Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12070-023-04309-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12070-023-04309-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12070-023-04309-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T13:04:56Z","timestamp":1711890296000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12070-023-04309-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,10]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["4309"],"URL":"https:\/\/doi.org\/10.1007\/s12070-023-04309-9","relation":{},"ISSN":["2231-3796","0973-7707"],"issn-type":[{"value":"2231-3796","type":"print"},{"value":"0973-7707","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,10]]},"assertion":[{"value":"9 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author has no conflicts of interest to declare. There is no financial interest to report. The author certifies that the submission is original work and is not under review at any other publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The research undertaken involved no human participants and\/or animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was not sought for this review as the methodology of the project did not involve the use of human and\/or animal subjects or participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}